Curie.Bio Email Format
Biotechnology ResearchRemote, United States51-200 Employees
Curie.Bio is a remote, United States–based biotechnology research firm that operates as a venture capital partner focused on advancing medicines. It supports founders by investing directly into existing companies, creating focused spinouts, and helping build new companies from scratch to accelerate therapeutic development. The firm reports managing about $1 billion for seed and Series A rounds and employs between 51 and 200 people, with a team whose work has contributed to more than 40 FDA-approved drugs. Curie.Bio emphasizes a capital-efficient, collaborative approach, working alongside founders to reach critical milestones. The company maintains a website at https://curie.bio.